Rocbrutinib plus R-CHOP yielded a 100% ORR and an 86.7% CR rate in 15 patients with untreated non-GCB DLBCL, warranting randomized evaluation.
Cam Schlittler won the 2026 Players Choice Awards American League Outstanding Pitcher beating fellow finalists Dylan Cease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results